AKT1 and pituitary tumor: Since aberrant activation of MAPK and PTEN/AKT signaling pathways has been associated with pathogenesis of pituitary tumors [25–27] we decided to check whether miR-410-3p overexpression affected activation of these pathways differently in the tested cell lines.